✦ LIBER ✦

The complexity of using D2-dopamine antagonists in the treatment of patients with schizophrenia

✍ Scribed by F.-A. Wiesel; L. Bjerkenstedt; G. Edman; L. Flyckt; N. Venizelos

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine D2 receptor gene polymorphisms

✍ NOBORU SAKUMOTO; TSUYOSHI KONDO; KAZUO MIHARA; AKIHITO SUZUKI; NORIO YASUI-FURUK 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Selective dopamine D2 antagonist, remoxi

✍ Awad, A.G.; Ancill, R.; Awad, A.G.; Bakish, D.; Beaudry, P.; Bloom, D.; Chouinar 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Ave5997, a dopamine D3 antagonist for th

✍ S. Kongsamut; J. Hendrix; K. Bordeau; J. Strupczewski; B. Harris; M. Kenney; S. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 126 KB

The new selective dopamine D2 antagonist

✍ Awad, A.G.; Lapierre, Y.D.; Nair, N.P.V.; Beaudry, P.; Saxena, B.; Chouinard, G. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Bioactive Heterocyclic Compound Classes

✍ Dinges, Jürgen; Lamberth, Clemens 📂 Article 📅 2013 🏛 Wiley-VCH Verlag GmbH & Co. KGaA ⚖ 163 KB

NNC 01-0687, a selective dopamine D1 rec

✍ J. Karle; H. Lublin; J. Gerlach; L. Clemmesen; L. Hansen; M. Andersen; J. Anders 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 218 KB